Shares of Novavax, Inc. (NVAX) plunged over 19.5% on Thursday after Health and Human Services Secretary Robert F. Kennedy Jr.

By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved a prefilled syringe version ...

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

President Trump's trade policies are sending many stocks that were performing well in the wrong direction and exacerbating ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.

Kennedy, a well-known vaccine skeptic, last week announced plans to reshape federal public health agencies, including cutting ...

While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...